Corporate Banner
Satellite Banner
Genotyping & Gene Expression
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Syros Pharmaceuticals Appoints Eric R. Olson, Ph.D. as Chief Scientific Officer

Published: Thursday, May 23, 2013
Last Updated: Thursday, May 23, 2013
Bookmark and Share
Dr. Olson’s extensive experience in personalized medicine will support Syros’ mission to lead in gene control.

Syros Pharmaceuticals announced that Eric R. Olson, Ph.D., has joined the company as its Chief Scientific Officer. Dr. Olson has over 25 years experience in the life sciences industry, most recently as Research Vice President for respiratory diseases at Vertex Pharmaceuticals. During his 12 years at Vertex he led research, development and commercial teams in bringing to patients the first cystic fibrosis (CF) treatment resulting from discovery of the CF gene.

“Eric is of the few people in the biopharma industry who have led programs from conception all the way through development and successful commercialization,” said Nancy Simonian, M.D., Syros’s Chief Executive Officer. “The combination of his deep scientific expertise, his understanding for translating science into drugs that actually help people, and his experience creating real value for shareholders is extraordinary. It fits perfectly with Syros' mission.”

In addition to his work at Vertex Pharmaceuticals, Dr. Olson has also held positions as the Director of the Antibacterials and Molecular Sciences departments at Warner-Lambert (now Pfizer), as well as a research scientist focused on gene expression systems with The Upjohn Company. Dr. Olson earned his B.S. in microbiology from the University of Minnesota and a Ph.D. in microbiology and immunology from the University of Michigan. He is published in over 40 academic journals.

“Syros Pharmaceuticals’ groundbreaking work in gene control and Super-Enhancers has created a unique, state-of-the-art opportunity to develop novel medicines focused on disease dependency genes,” said Dr. Olson. “I am excited to lead the scientific efforts at a company conducting this type of innovative research, and look forward to working with Syros’ experienced management team and renowned scientific advisory board to develop new breakthrough therapies.”


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Poor Survival Rates in Leukemia Linked to Persistent Genetic Mutations
For patients with an often-deadly form of leukemia, new research suggests that lingering cancer-related mutations – detected after initial treatment with chemotherapy – are associated with an increased risk of relapse and poor survival.
Marijuana Genome Unraveled
A study by Canadian researchers is providing a clearer picture of the evolutionary history and genetic organization of cannabis, a step that could have agricultural, medical and legal implications for this valuable crop.
Growing Hepatitis C in the Lab
Recent discovery allows study of naturally occurring forms of hepatitis C virus (HCV) in the lab.
Signature of Microbiomes Linked to Schizophrenia
Studying microbiomes in throat may help identify causes and treatments of brain disorder.
Study Identifies the Off Switch for Biofilm Formation
New discovery could help prevent the formation of infectious bacterial films on hospital equipment.
Genetic Overlapping in Multiple Autoimmune Diseases May Suggest Common Therapies
CHOP genomics expert leads analysis of genetic architecture, with eye on repurposing existing drugs.
Fat in the Family?
Study could lead to therapeutics that boost metabolism.
Combo Tool
Joining molecular components expands ability to manipulate genes in specific cell types.
Team Identifies Structure of Tumor-Suppressing Protein
An international group of researchers led by Carnegie Mellon University physicists Mathias Lösche and Frank Heinrich have established the structure of an important tumor suppressing protein, PTEN.
Genes Associated With Improved Survival for Pancreatic Cancer Patients
Use of non-invasive liquid biopsies could predict in which patients the cancer could recur following surgery.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!